Home / Cancer and immune system / Alpelisib
ATC L01EM03 · Phosphatidylinositol-3-Kinase (Pi3K) Inhibitors
Alpelisib shortage
As of 2 Nov 2026, Alpelisib has a reported shortage in 1 of the 16 countries we track (Canada), covering 1 product from 1 company.
Countries1/16
Products1packs or presentations
Companies11 listed
Short since–
Earliest returnnot givencompany estimate
Main reasonNot stated
United StatesNo reported shortageCanada1 product shortGermanyNo reported shortageFranceNo reported shortageItalyNo reported shortageSpainNo reported shortageIrelandNo reported shortageAustriaNo reported shortageBelgiumNo reported shortageSwitzerlandNo reported shortageCzechiaNo reported shortageNorwayNo reported shortageSwedenNo reported shortageJapanNo reported shortageNew ZealandNo reported shortageAustraliaNo reported shortage
Which companies are short
products short, all countriesListed: Novartis NOVN · SIX Swiss
Compared with similar medicines
ATC group L01EM · Phosphatidylinositol-3-Kinase (Pi3K) InhibitorsAffected products
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | PIQRAY (2 blister packs of 14) discontinuation | NOVARTIS PHARMACEUTICALS CANADA INC | not given | not given | Not stated |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.